血管内修复与瘤动脉瘤手术对比:使用贝叶斯推理进行的回顾性研究
Taiji Koyama1, Kentaro Iwata2, Katsuhiro Yamanaka3
1Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
Surgery in practice and science
|January 23, 2025
概括
当手术不可行时,内血管动脉瘤修复 (EVAR/TEVAR) 可能是真菌动脉瘤的选择,尽管手术修复 (SR) 在这种罕见感染研究中显示了更长的存活率.
科学领域:
- 血管外科 血管外科
- 传染性疾病 传染性疾病
- 医疗技术 医疗技术 医学技术
背景情况:
- 菌性动脉瘤是一种罕见的感染,因此很难评估治疗的有效性.
- 内血管动脉瘤修复 (EVAR) 和胸内血管大动脉修复 (TEVAR) 是新兴的治疗选择.
研究的目的:
- 为了比较EVAR/TEVAR与菌动脉瘤传统手术修复 (SR) 的有效性.
- 为了评估患者的生存结果在EVAR/TEVAR和SR之间.
主要方法:
- 一项回顾性队列研究包括38名患有菌性动脉瘤的患者,这些患者在2008年至2015年期间被诊断为菌性动脉瘤.
- 患者被分为EVAR/TEVAR (n=8) 和SR (n=30) 组.
- 考克斯比例回归和贝叶斯推理用于生存分析.
主要成果:
- EVAR/TEVAR的中位生存时间为916天,SR的中位生存时间为1550天.
- 考克斯模型危险比 (HR) 为2.25 (p=0.11);贝叶斯HR为1.68 (95%可信区间为0.68-4.35).
- 手术后的预期寿命在手术修复后往往更长.
结论:
- 在真菌性动脉瘤病例中,手术修复与更长的术后预期寿命有关.
- 当真菌性动脉瘤无法进行手术修复时,Evar/TEVAR提供了一个可行的替代方案.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Aneurysm III: Interprofessional Care
478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478


